Followers

0
0
2
2
.
7
7
2
2
9
9
5.45 (0.59%)

As on 17 Oct, 2025 | 15:57

Open Trading A/c
Day Range
914.30
930.60
LH
52 Week Range
665.10
1,198.25
LH
Volume
* i
Bid / Ask
18,410.00
0.00 / 0.00

Windlas Biotech Announcements

Certificate under Regulation 74(5) of SEBI (Depository Participants) Regulations, 2018 for the quarter ended September 30, 2025

08 Oct, 2025 | 12:49pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

03 Oct, 2025 | 05:53pm • Source: BSE

Intimation for closure of trading window

29 Sep, 2025 | 04:57pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

10 Sep, 2025 | 06:00pm • Source: BSE

Appointment of Investor Relations Agency

01 Sep, 2025 | 06:22pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

01 Sep, 2025 | 01:26pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

28 Aug, 2025 | 01:06pm • Source: BSE

Outcome of the Nomination and Remuneration Committee Meeting

24 Aug, 2025 | 10:07pm • Source: BSE

Q1 FY26 earnings conference call transcript

21 Aug, 2025 | 03:53pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

18 Aug, 2025 | 02:00pm • Source: BSE

Link of Audio Recording of the Earnings Call held on August 13, 2025

13 Aug, 2025 | 05:21pm • Source: BSE

Press Release on Q1 of FY26 Financial Results

12 Aug, 2025 | 03:30pm • Source: BSE

Results presentation for the Q1 of FY26

12 Aug, 2025 | 03:22pm • Source: BSE

Outcome of the Board Meeting held on August 12, 2025

12 Aug, 2025 | 03:13pm • Source: BSE

Outcome of the Board Meeting held on August 12, 2025

12 Aug, 2025 | 03:08pm • Source: BSE

Schedule of Conference Call to discuss financial performance of the Company for quarter ended June 30, 2025

06 Aug, 2025 | 04:23pm • Source: BSE

Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and...

06 Aug, 2025 | 02:33pm • Source: BSE

Submission of Combined Voting Results along with the Scrutiniser''s Report under Regulation 44(3) of the SEBI LODR Regulations, 2015 of the 24th AGM held on...

29 Jul, 2025 | 06:04pm • Source: BSE